nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—SLC29A2—Mercaptopurine—Crohn's disease	0.52	0.609	CbGbCtD
Zalcitabine—SLC29A1—Mercaptopurine—Crohn's disease	0.299	0.35	CbGbCtD
Zalcitabine—CYP3A5—Sulfasalazine—Crohn's disease	0.0266	0.0312	CbGbCtD
Zalcitabine—CYP3A4—Prednisone—Crohn's disease	0.00831	0.00972	CbGbCtD
Zalcitabine—Decitabine—DNMT3A—Crohn's disease	0.0057	1	CrCbGaD
Zalcitabine—Rash erythematous—Mesalazine—Crohn's disease	0.000867	0.0064	CcSEcCtD
Zalcitabine—Liver injury—Azathioprine—Crohn's disease	0.000867	0.0064	CcSEcCtD
Zalcitabine—Dementia—Prednisone—Crohn's disease	0.000857	0.00632	CcSEcCtD
Zalcitabine—Rhinorrhoea—Mesalazine—Crohn's disease	0.00082	0.00605	CcSEcCtD
Zalcitabine—Liver injury—Mesalazine—Crohn's disease	0.000789	0.00583	CcSEcCtD
Zalcitabine—Tenderness—Mesalazine—Crohn's disease	0.000761	0.00562	CcSEcCtD
Zalcitabine—Pancreatitis acute—Prednisone—Crohn's disease	0.000761	0.00562	CcSEcCtD
Zalcitabine—Pancreatitis—Mercaptopurine—Crohn's disease	0.000753	0.00556	CcSEcCtD
Zalcitabine—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00074	0.00547	CcSEcCtD
Zalcitabine—Endophthalmitis—Prednisone—Crohn's disease	0.000738	0.00545	CcSEcCtD
Zalcitabine—Rectal haemorrhage—Mesalazine—Crohn's disease	0.000735	0.00543	CcSEcCtD
Zalcitabine—Arthropathy—Mesalazine—Crohn's disease	0.00073	0.00539	CcSEcCtD
Zalcitabine—Oropharyngeal pain—Mesalazine—Crohn's disease	0.00073	0.00539	CcSEcCtD
Zalcitabine—Hepatocellular injury—Azathioprine—Crohn's disease	0.000729	0.00538	CcSEcCtD
Zalcitabine—Hypocalcaemia—Mesalazine—Crohn's disease	0.000726	0.00536	CcSEcCtD
Zalcitabine—DCK—Desoximetasone—Prednisone—Crohn's disease	0.000724	0.508	CbGdCrCtD
Zalcitabine—Gout—Mesalazine—Crohn's disease	0.000711	0.00525	CcSEcCtD
Zalcitabine—DCK—Diflorasone—Prednisone—Crohn's disease	0.000702	0.493	CbGdCrCtD
Zalcitabine—Colitis—Azathioprine—Crohn's disease	0.0007	0.00517	CcSEcCtD
Zalcitabine—Neck pain—Mesalazine—Crohn's disease	0.000672	0.00496	CcSEcCtD
Zalcitabine—Hypernatraemia—Prednisone—Crohn's disease	0.000668	0.00493	CcSEcCtD
Zalcitabine—Hepatocellular injury—Mesalazine—Crohn's disease	0.000664	0.0049	CcSEcCtD
Zalcitabine—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.000664	0.0049	CcSEcCtD
Zalcitabine—Eructation—Mesalazine—Crohn's disease	0.000653	0.00482	CcSEcCtD
Zalcitabine—Melaena—Mesalazine—Crohn's disease	0.000649	0.00479	CcSEcCtD
Zalcitabine—Influenza like illness—Mesalazine—Crohn's disease	0.000645	0.00476	CcSEcCtD
Zalcitabine—Colitis—Mesalazine—Crohn's disease	0.000638	0.00471	CcSEcCtD
Zalcitabine—Skin exfoliation—Mesalazine—Crohn's disease	0.000634	0.00468	CcSEcCtD
Zalcitabine—Candida infection—Mesalazine—Crohn's disease	0.000634	0.00468	CcSEcCtD
Zalcitabine—Blood urea increased—Mesalazine—Crohn's disease	0.000627	0.00463	CcSEcCtD
Zalcitabine—Vaginal infection—Mesalazine—Crohn's disease	0.000627	0.00463	CcSEcCtD
Zalcitabine—Dry eye—Mesalazine—Crohn's disease	0.000613	0.00453	CcSEcCtD
Zalcitabine—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00061	0.0045	CcSEcCtD
Zalcitabine—Bladder pain—Mesalazine—Crohn's disease	0.000601	0.00443	CcSEcCtD
Zalcitabine—Hypertonia—Mesalazine—Crohn's disease	0.000582	0.0043	CcSEcCtD
Zalcitabine—Ear pain—Mesalazine—Crohn's disease	0.000565	0.00417	CcSEcCtD
Zalcitabine—Lymphadenopathy—Mesalazine—Crohn's disease	0.000565	0.00417	CcSEcCtD
Zalcitabine—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.000554	0.00409	CcSEcCtD
Zalcitabine—Alopecia—Mercaptopurine—Crohn's disease	0.000543	0.00401	CcSEcCtD
Zalcitabine—Deafness—Mesalazine—Crohn's disease	0.000539	0.00398	CcSEcCtD
Zalcitabine—Eye pain—Mesalazine—Crohn's disease	0.000534	0.00394	CcSEcCtD
Zalcitabine—Renal failure acute—Mesalazine—Crohn's disease	0.000522	0.00385	CcSEcCtD
Zalcitabine—Libido decreased—Mesalazine—Crohn's disease	0.00052	0.00384	CcSEcCtD
Zalcitabine—Atrial fibrillation—Mesalazine—Crohn's disease	0.000509	0.00376	CcSEcCtD
Zalcitabine—Renal impairment—Mesalazine—Crohn's disease	0.000507	0.00374	CcSEcCtD
Zalcitabine—Dermatitis bullous—Mesalazine—Crohn's disease	0.000504	0.00372	CcSEcCtD
Zalcitabine—Myopathy—Prednisone—Crohn's disease	0.000501	0.0037	CcSEcCtD
Zalcitabine—Hepatomegaly—Prednisone—Crohn's disease	0.000496	0.00366	CcSEcCtD
Zalcitabine—Arthritis—Mesalazine—Crohn's disease	0.000496	0.00366	CcSEcCtD
Zalcitabine—Anaemia—Mercaptopurine—Crohn's disease	0.000494	0.00365	CcSEcCtD
Zalcitabine—Mania—Prednisone—Crohn's disease	0.000483	0.00357	CcSEcCtD
Zalcitabine—Osteoarthritis—Mesalazine—Crohn's disease	0.000482	0.00356	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000482	0.00356	CcSEcCtD
Zalcitabine—Leukopenia—Mercaptopurine—Crohn's disease	0.000479	0.00353	CcSEcCtD
Zalcitabine—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.000478	0.00353	CcSEcCtD
Zalcitabine—Affect lability—Mesalazine—Crohn's disease	0.000475	0.0035	CcSEcCtD
Zalcitabine—Migraine—Mesalazine—Crohn's disease	0.000475	0.0035	CcSEcCtD
Zalcitabine—Neuritis—Prednisone—Crohn's disease	0.000471	0.00347	CcSEcCtD
Zalcitabine—Mood swings—Mesalazine—Crohn's disease	0.000457	0.00337	CcSEcCtD
Zalcitabine—Arthralgia—Mercaptopurine—Crohn's disease	0.000455	0.00336	CcSEcCtD
Zalcitabine—Blood creatinine increased—Mesalazine—Crohn's disease	0.000452	0.00333	CcSEcCtD
Zalcitabine—Pancreatitis—Azathioprine—Crohn's disease	0.000449	0.00331	CcSEcCtD
Zalcitabine—Dry skin—Mesalazine—Crohn's disease	0.000442	0.00326	CcSEcCtD
Zalcitabine—Abdominal pain upper—Mesalazine—Crohn's disease	0.00044	0.00325	CcSEcCtD
Zalcitabine—Oedema—Mercaptopurine—Crohn's disease	0.000437	0.00322	CcSEcCtD
Zalcitabine—Cramp muscle—Mesalazine—Crohn's disease	0.000434	0.0032	CcSEcCtD
Zalcitabine—Glycosuria—Prednisone—Crohn's disease	0.000434	0.0032	CcSEcCtD
Zalcitabine—Nasopharyngitis—Mesalazine—Crohn's disease	0.000431	0.00318	CcSEcCtD
Zalcitabine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000428	0.00316	CcSEcCtD
Zalcitabine—Gastritis—Mesalazine—Crohn's disease	0.000427	0.00315	CcSEcCtD
Zalcitabine—Skin disorder—Mercaptopurine—Crohn's disease	0.000424	0.00313	CcSEcCtD
Zalcitabine—Abdominal distension—Mesalazine—Crohn's disease	0.00042	0.0031	CcSEcCtD
Zalcitabine—Dysphagia—Mesalazine—Crohn's disease	0.000417	0.00308	CcSEcCtD
Zalcitabine—Anorexia—Mercaptopurine—Crohn's disease	0.000416	0.00307	CcSEcCtD
Zalcitabine—Eosinophilia—Mesalazine—Crohn's disease	0.000413	0.00305	CcSEcCtD
Zalcitabine—Pancreatitis—Mesalazine—Crohn's disease	0.000409	0.00302	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000398	0.00294	CcSEcCtD
Zalcitabine—Dysuria—Mesalazine—Crohn's disease	0.00039	0.00288	CcSEcCtD
Zalcitabine—Neutropenia—Mesalazine—Crohn's disease	0.00039	0.00288	CcSEcCtD
Zalcitabine—Arthropathy—Prednisone—Crohn's disease	0.000386	0.00285	CcSEcCtD
Zalcitabine—Pollakiuria—Mesalazine—Crohn's disease	0.000385	0.00284	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00038	0.00281	CcSEcCtD
Zalcitabine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00038	0.0028	CcSEcCtD
Zalcitabine—Weight decreased—Mesalazine—Crohn's disease	0.000377	0.00278	CcSEcCtD
Zalcitabine—Ulcer—Prednisone—Crohn's disease	0.000372	0.00274	CcSEcCtD
Zalcitabine—Depression—Mesalazine—Crohn's disease	0.00037	0.00273	CcSEcCtD
Zalcitabine—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.000366	0.117	CbGpPWpGaD
Zalcitabine—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.000366	0.117	CbGpPWpGaD
Zalcitabine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000364	0.00269	CcSEcCtD
Zalcitabine—Jaundice—Mesalazine—Crohn's disease	0.000362	0.00267	CcSEcCtD
Zalcitabine—Epistaxis—Mesalazine—Crohn's disease	0.00035	0.00259	CcSEcCtD
Zalcitabine—Sinusitis—Mesalazine—Crohn's disease	0.000349	0.00257	CcSEcCtD
Zalcitabine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000345	0.00255	CcSEcCtD
Zalcitabine—Skin exfoliation—Prednisone—Crohn's disease	0.000336	0.00248	CcSEcCtD
Zalcitabine—Rhinitis—Mesalazine—Crohn's disease	0.000334	0.00247	CcSEcCtD
Zalcitabine—Hepatitis—Mesalazine—Crohn's disease	0.000334	0.00246	CcSEcCtD
Zalcitabine—Pharyngitis—Mesalazine—Crohn's disease	0.000331	0.00244	CcSEcCtD
Zalcitabine—Chills—Azathioprine—Crohn's disease	0.000329	0.00243	CcSEcCtD
Zalcitabine—Arrhythmia—Azathioprine—Crohn's disease	0.000327	0.00241	CcSEcCtD
Zalcitabine—Alopecia—Azathioprine—Crohn's disease	0.000324	0.00239	CcSEcCtD
Zalcitabine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000322	0.00237	CcSEcCtD
Zalcitabine—Oesophagitis—Prednisone—Crohn's disease	0.000321	0.00237	CcSEcCtD
Zalcitabine—Eye disorder—Mesalazine—Crohn's disease	0.000312	0.0023	CcSEcCtD
Zalcitabine—Tinnitus—Mesalazine—Crohn's disease	0.000311	0.0023	CcSEcCtD
Zalcitabine—Hyperkinesia—Prednisone—Crohn's disease	0.000306	0.00226	CcSEcCtD
Zalcitabine—Euphoric mood—Prednisone—Crohn's disease	0.000302	0.00223	CcSEcCtD
Zalcitabine—Chills—Mesalazine—Crohn's disease	0.000299	0.00221	CcSEcCtD
Zalcitabine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000299	0.00221	CcSEcCtD
Zalcitabine—Ill-defined disorder—Azathioprine—Crohn's disease	0.000296	0.00218	CcSEcCtD
Zalcitabine—Alopecia—Mesalazine—Crohn's disease	0.000295	0.00218	CcSEcCtD
Zalcitabine—Anaemia—Azathioprine—Crohn's disease	0.000295	0.00217	CcSEcCtD
Zalcitabine—Diabetes mellitus—Prednisone—Crohn's disease	0.000293	0.00216	CcSEcCtD
Zalcitabine—Malaise—Azathioprine—Crohn's disease	0.000287	0.00212	CcSEcCtD
Zalcitabine—Flatulence—Mesalazine—Crohn's disease	0.000286	0.00211	CcSEcCtD
Zalcitabine—Leukopenia—Azathioprine—Crohn's disease	0.000285	0.00211	CcSEcCtD
Zalcitabine—Vascular purpura—Prednisone—Crohn's disease	0.000285	0.0021	CcSEcCtD
Zalcitabine—Tension—Mesalazine—Crohn's disease	0.000285	0.0021	CcSEcCtD
Zalcitabine—Dysgeusia—Mesalazine—Crohn's disease	0.000284	0.0021	CcSEcCtD
Zalcitabine—Nervousness—Mesalazine—Crohn's disease	0.000282	0.00208	CcSEcCtD
Zalcitabine—Back pain—Mesalazine—Crohn's disease	0.000281	0.00207	CcSEcCtD
Zalcitabine—Muscle spasms—Mesalazine—Crohn's disease	0.000279	0.00206	CcSEcCtD
Zalcitabine—Vomiting—Mercaptopurine—Crohn's disease	0.000278	0.00205	CcSEcCtD
Zalcitabine—Rash—Mercaptopurine—Crohn's disease	0.000275	0.00203	CcSEcCtD
Zalcitabine—Dermatitis—Mercaptopurine—Crohn's disease	0.000275	0.00203	CcSEcCtD
Zalcitabine—Vision blurred—Mesalazine—Crohn's disease	0.000274	0.00202	CcSEcCtD
Zalcitabine—Tremor—Mesalazine—Crohn's disease	0.000272	0.00201	CcSEcCtD
Zalcitabine—Amnesia—Prednisone—Crohn's disease	0.000272	0.002	CcSEcCtD
Zalcitabine—Myalgia—Azathioprine—Crohn's disease	0.000271	0.002	CcSEcCtD
Zalcitabine—Arthralgia—Azathioprine—Crohn's disease	0.000271	0.002	CcSEcCtD
Zalcitabine—Ill-defined disorder—Mesalazine—Crohn's disease	0.000269	0.00199	CcSEcCtD
Zalcitabine—Anaemia—Mesalazine—Crohn's disease	0.000268	0.00198	CcSEcCtD
Zalcitabine—Discomfort—Azathioprine—Crohn's disease	0.000268	0.00198	CcSEcCtD
Zalcitabine—Purpura—Prednisone—Crohn's disease	0.000265	0.00195	CcSEcCtD
Zalcitabine—Malaise—Mesalazine—Crohn's disease	0.000262	0.00193	CcSEcCtD
Zalcitabine—Cardiac failure—Prednisone—Crohn's disease	0.000261	0.00193	CcSEcCtD
Zalcitabine—Vertigo—Mesalazine—Crohn's disease	0.000261	0.00193	CcSEcCtD
Zalcitabine—Syncope—Mesalazine—Crohn's disease	0.00026	0.00192	CcSEcCtD
Zalcitabine—Leukopenia—Mesalazine—Crohn's disease	0.00026	0.00192	CcSEcCtD
Zalcitabine—Infection—Azathioprine—Crohn's disease	0.000258	0.00191	CcSEcCtD
Zalcitabine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.000257	0.0819	CbGpPWpGaD
Zalcitabine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.000257	0.0819	CbGpPWpGaD
Zalcitabine—Palpitations—Mesalazine—Crohn's disease	0.000257	0.00189	CcSEcCtD
Zalcitabine—Loss of consciousness—Mesalazine—Crohn's disease	0.000255	0.00188	CcSEcCtD
Zalcitabine—Osteoarthritis—Prednisone—Crohn's disease	0.000255	0.00188	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000255	0.00188	CcSEcCtD
Zalcitabine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000255	0.00188	CcSEcCtD
Zalcitabine—Cough—Mesalazine—Crohn's disease	0.000253	0.00187	CcSEcCtD
Zalcitabine—Skin disorder—Azathioprine—Crohn's disease	0.000253	0.00187	CcSEcCtD
Zalcitabine—Affect lability—Prednisone—Crohn's disease	0.000251	0.00185	CcSEcCtD
Zalcitabine—Hypertension—Mesalazine—Crohn's disease	0.000251	0.00185	CcSEcCtD
Zalcitabine—Psychotic disorder—Prednisone—Crohn's disease	0.000249	0.00184	CcSEcCtD
Zalcitabine—Arthralgia—Mesalazine—Crohn's disease	0.000247	0.00182	CcSEcCtD
Zalcitabine—Myalgia—Mesalazine—Crohn's disease	0.000247	0.00182	CcSEcCtD
Zalcitabine—Anxiety—Mesalazine—Crohn's disease	0.000246	0.00182	CcSEcCtD
Zalcitabine—Discomfort—Mesalazine—Crohn's disease	0.000244	0.0018	CcSEcCtD
Zalcitabine—Dry mouth—Mesalazine—Crohn's disease	0.000242	0.00178	CcSEcCtD
Zalcitabine—Mood swings—Prednisone—Crohn's disease	0.000242	0.00178	CcSEcCtD
Zalcitabine—Confusional state—Mesalazine—Crohn's disease	0.000239	0.00176	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000237	0.00175	CcSEcCtD
Zalcitabine—Oedema—Mesalazine—Crohn's disease	0.000237	0.00175	CcSEcCtD
Zalcitabine—Infection—Mesalazine—Crohn's disease	0.000235	0.00174	CcSEcCtD
Zalcitabine—Dry skin—Prednisone—Crohn's disease	0.000234	0.00173	CcSEcCtD
Zalcitabine—Shock—Mesalazine—Crohn's disease	0.000233	0.00172	CcSEcCtD
Zalcitabine—Hypokalaemia—Prednisone—Crohn's disease	0.000232	0.00171	CcSEcCtD
Zalcitabine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000232	0.00171	CcSEcCtD
Zalcitabine—Tachycardia—Mesalazine—Crohn's disease	0.000231	0.00171	CcSEcCtD
Zalcitabine—Skin disorder—Mesalazine—Crohn's disease	0.00023	0.0017	CcSEcCtD
Zalcitabine—Hyperhidrosis—Mesalazine—Crohn's disease	0.000229	0.00169	CcSEcCtD
Zalcitabine—Anorexia—Mesalazine—Crohn's disease	0.000226	0.00167	CcSEcCtD
Zalcitabine—Muscular weakness—Prednisone—Crohn's disease	0.000225	0.00166	CcSEcCtD
Zalcitabine—Abdominal distension—Prednisone—Crohn's disease	0.000222	0.00164	CcSEcCtD
Zalcitabine—Pancreatitis—Prednisone—Crohn's disease	0.000216	0.0016	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000216	0.00159	CcSEcCtD
Zalcitabine—Sweating increased—Prednisone—Crohn's disease	0.000215	0.00159	CcSEcCtD
Zalcitabine—Feeling abnormal—Azathioprine—Crohn's disease	0.000214	0.00158	CcSEcCtD
Zalcitabine—Insomnia—Mesalazine—Crohn's disease	0.000214	0.00158	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000213	0.00157	CcSEcCtD
Zalcitabine—Dyspnoea—Mesalazine—Crohn's disease	0.000211	0.00156	CcSEcCtD
Zalcitabine—Somnolence—Mesalazine—Crohn's disease	0.000211	0.00156	CcSEcCtD
Zalcitabine—Dyspepsia—Mesalazine—Crohn's disease	0.000209	0.00154	CcSEcCtD
Zalcitabine—Neutropenia—Prednisone—Crohn's disease	0.000206	0.00152	CcSEcCtD
Zalcitabine—Decreased appetite—Mesalazine—Crohn's disease	0.000206	0.00152	CcSEcCtD
Zalcitabine—Body temperature increased—Azathioprine—Crohn's disease	0.000206	0.00152	CcSEcCtD
Zalcitabine—Abdominal pain—Azathioprine—Crohn's disease	0.000206	0.00152	CcSEcCtD
Zalcitabine—Fatigue—Mesalazine—Crohn's disease	0.000204	0.00151	CcSEcCtD
Zalcitabine—Pain—Mesalazine—Crohn's disease	0.000203	0.0015	CcSEcCtD
Zalcitabine—Weight decreased—Prednisone—Crohn's disease	0.000199	0.00147	CcSEcCtD
Zalcitabine—Hyperglycaemia—Prednisone—Crohn's disease	0.000199	0.00147	CcSEcCtD
Zalcitabine—Depression—Prednisone—Crohn's disease	0.000196	0.00145	CcSEcCtD
Zalcitabine—Feeling abnormal—Mesalazine—Crohn's disease	0.000195	0.00144	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000194	0.00143	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Prednisone—Crohn's disease	0.000193	0.00142	CcSEcCtD
Zalcitabine—Hypersensitivity—Azathioprine—Crohn's disease	0.000192	0.00141	CcSEcCtD
Zalcitabine—Urticaria—Mesalazine—Crohn's disease	0.000188	0.00139	CcSEcCtD
Zalcitabine—Body temperature increased—Mesalazine—Crohn's disease	0.000187	0.00138	CcSEcCtD
Zalcitabine—Abdominal pain—Mesalazine—Crohn's disease	0.000187	0.00138	CcSEcCtD
Zalcitabine—Diarrhoea—Azathioprine—Crohn's disease	0.000178	0.00131	CcSEcCtD
Zalcitabine—Hallucination—Prednisone—Crohn's disease	0.000176	0.0013	CcSEcCtD
Zalcitabine—Hypersensitivity—Mesalazine—Crohn's disease	0.000175	0.00129	CcSEcCtD
Zalcitabine—Dizziness—Azathioprine—Crohn's disease	0.000172	0.00127	CcSEcCtD
Zalcitabine—Asthenia—Mesalazine—Crohn's disease	0.00017	0.00126	CcSEcCtD
Zalcitabine—Pruritus—Mesalazine—Crohn's disease	0.000168	0.00124	CcSEcCtD
Zalcitabine—Vomiting—Azathioprine—Crohn's disease	0.000165	0.00122	CcSEcCtD
Zalcitabine—Eye disorder—Prednisone—Crohn's disease	0.000165	0.00122	CcSEcCtD
Zalcitabine—Rash—Azathioprine—Crohn's disease	0.000164	0.00121	CcSEcCtD
Zalcitabine—Dermatitis—Azathioprine—Crohn's disease	0.000164	0.00121	CcSEcCtD
Zalcitabine—Flushing—Prednisone—Crohn's disease	0.000164	0.00121	CcSEcCtD
Zalcitabine—Headache—Azathioprine—Crohn's disease	0.000163	0.0012	CcSEcCtD
Zalcitabine—Diarrhoea—Mesalazine—Crohn's disease	0.000162	0.0012	CcSEcCtD
Zalcitabine—Arrhythmia—Prednisone—Crohn's disease	0.000158	0.00116	CcSEcCtD
Zalcitabine—Dizziness—Mesalazine—Crohn's disease	0.000157	0.00116	CcSEcCtD
Zalcitabine—Alopecia—Prednisone—Crohn's disease	0.000156	0.00115	CcSEcCtD
Zalcitabine—Vomiting—Mesalazine—Crohn's disease	0.000151	0.00111	CcSEcCtD
Zalcitabine—Rash—Mesalazine—Crohn's disease	0.000149	0.0011	CcSEcCtD
Zalcitabine—Dermatitis—Mesalazine—Crohn's disease	0.000149	0.0011	CcSEcCtD
Zalcitabine—Headache—Mesalazine—Crohn's disease	0.000148	0.0011	CcSEcCtD
Zalcitabine—Vision blurred—Prednisone—Crohn's disease	0.000145	0.00107	CcSEcCtD
Zalcitabine—Ill-defined disorder—Prednisone—Crohn's disease	0.000143	0.00105	CcSEcCtD
Zalcitabine—Anaemia—Prednisone—Crohn's disease	0.000142	0.00105	CcSEcCtD
Zalcitabine—Agitation—Prednisone—Crohn's disease	0.000141	0.00104	CcSEcCtD
Zalcitabine—Malaise—Prednisone—Crohn's disease	0.000139	0.00102	CcSEcCtD
Zalcitabine—Vertigo—Prednisone—Crohn's disease	0.000138	0.00102	CcSEcCtD
Zalcitabine—Syncope—Prednisone—Crohn's disease	0.000138	0.00102	CcSEcCtD
Zalcitabine—Loss of consciousness—Prednisone—Crohn's disease	0.000135	0.000997	CcSEcCtD
Zalcitabine—Convulsion—Prednisone—Crohn's disease	0.000133	0.000983	CcSEcCtD
Zalcitabine—Hypertension—Prednisone—Crohn's disease	0.000133	0.000979	CcSEcCtD
Zalcitabine—Myalgia—Prednisone—Crohn's disease	0.000131	0.000965	CcSEcCtD
Zalcitabine—Arthralgia—Prednisone—Crohn's disease	0.000131	0.000965	CcSEcCtD
Zalcitabine—Anxiety—Prednisone—Crohn's disease	0.00013	0.000962	CcSEcCtD
Zalcitabine—Discomfort—Prednisone—Crohn's disease	0.000129	0.000954	CcSEcCtD
Zalcitabine—Oedema—Prednisone—Crohn's disease	0.000125	0.000925	CcSEcCtD
Zalcitabine—Infection—Prednisone—Crohn's disease	0.000125	0.000919	CcSEcCtD
Zalcitabine—Shock—Prednisone—Crohn's disease	0.000123	0.000911	CcSEcCtD
Zalcitabine—Tachycardia—Prednisone—Crohn's disease	0.000122	0.000903	CcSEcCtD
Zalcitabine—Skin disorder—Prednisone—Crohn's disease	0.000122	0.000899	CcSEcCtD
Zalcitabine—Hyperhidrosis—Prednisone—Crohn's disease	0.000121	0.000895	CcSEcCtD
Zalcitabine—Anorexia—Prednisone—Crohn's disease	0.00012	0.000882	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000114	0.000843	CcSEcCtD
Zalcitabine—Insomnia—Prednisone—Crohn's disease	0.000113	0.000837	CcSEcCtD
Zalcitabine—Dyspepsia—Prednisone—Crohn's disease	0.00011	0.000815	CcSEcCtD
Zalcitabine—Decreased appetite—Prednisone—Crohn's disease	0.000109	0.000805	CcSEcCtD
Zalcitabine—Fatigue—Prednisone—Crohn's disease	0.000108	0.000798	CcSEcCtD
Zalcitabine—Feeling abnormal—Prednisone—Crohn's disease	0.000103	0.000763	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000103	0.000757	CcSEcCtD
Zalcitabine—Urticaria—Prednisone—Crohn's disease	9.96e-05	0.000735	CcSEcCtD
Zalcitabine—Abdominal pain—Prednisone—Crohn's disease	9.91e-05	0.000732	CcSEcCtD
Zalcitabine—Body temperature increased—Prednisone—Crohn's disease	9.91e-05	0.000732	CcSEcCtD
Zalcitabine—Hypersensitivity—Prednisone—Crohn's disease	9.24e-05	0.000682	CcSEcCtD
Zalcitabine—Asthenia—Prednisone—Crohn's disease	9e-05	0.000664	CcSEcCtD
Zalcitabine—Pruritus—Prednisone—Crohn's disease	8.87e-05	0.000655	CcSEcCtD
Zalcitabine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	8.82e-05	0.0281	CbGpPWpGaD
Zalcitabine—Diarrhoea—Prednisone—Crohn's disease	8.58e-05	0.000633	CcSEcCtD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	8.44e-05	0.0269	CbGpPWpGaD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	8.44e-05	0.0269	CbGpPWpGaD
Zalcitabine—Dizziness—Prednisone—Crohn's disease	8.29e-05	0.000612	CcSEcCtD
Zalcitabine—Vomiting—Prednisone—Crohn's disease	7.97e-05	0.000588	CcSEcCtD
Zalcitabine—Rash—Prednisone—Crohn's disease	7.91e-05	0.000584	CcSEcCtD
Zalcitabine—Dermatitis—Prednisone—Crohn's disease	7.9e-05	0.000583	CcSEcCtD
Zalcitabine—Headache—Prednisone—Crohn's disease	7.85e-05	0.00058	CcSEcCtD
Zalcitabine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	7.34e-05	0.0234	CbGpPWpGaD
Zalcitabine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	7.34e-05	0.0234	CbGpPWpGaD
Zalcitabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	6.11e-05	0.0195	CbGpPWpGaD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	5.95e-05	0.0189	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	5.85e-05	0.0186	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	5.85e-05	0.0186	CbGpPWpGaD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	5.26e-05	0.0167	CbGpPWpGaD
Zalcitabine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	5.15e-05	0.0164	CbGpPWpGaD
Zalcitabine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	5.15e-05	0.0164	CbGpPWpGaD
Zalcitabine—CYP3A43—Metapathway biotransformation—GPX4—Crohn's disease	4.85e-05	0.0155	CbGpPWpGaD
Zalcitabine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	4.57e-05	0.0146	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.29e-05	0.0137	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.29e-05	0.0137	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	4.12e-05	0.0131	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	3.64e-05	0.0116	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	3.33e-05	0.0106	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	3.33e-05	0.0106	CbGpPWpGaD
Zalcitabine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	3.21e-05	0.0102	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.02e-05	0.00963	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	2.97e-05	0.00947	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	2.97e-05	0.00947	CbGpPWpGaD
Zalcitabine—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	2.71e-05	0.00865	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.67e-05	0.00851	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—GCKR—Crohn's disease	2.35e-05	0.00748	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	2.34e-05	0.00745	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	2.34e-05	0.00745	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.09e-05	0.00667	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	2.08e-05	0.00662	CbGpPWpGaD
Zalcitabine—CYP3A7—Metapathway biotransformation—GPX4—Crohn's disease	1.96e-05	0.00623	CbGpPWpGaD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.89e-05	0.00603	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.85e-05	0.0059	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.69e-05	0.0054	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.69e-05	0.0054	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	1.65e-05	0.00525	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	1.46e-05	0.00464	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	1.41e-05	0.0045	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PLA2G4F—Crohn's disease	1.38e-05	0.00439	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PLA2G4F—Crohn's disease	1.36e-05	0.00432	CbGpPWpGaD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.31e-05	0.00418	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.19e-05	0.0038	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.19e-05	0.00379	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.19e-05	0.00379	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—MTMR3—Crohn's disease	1.17e-05	0.00373	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—MTMR3—Crohn's disease	1.15e-05	0.00368	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.06e-05	0.00336	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	1.01e-05	0.0032	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	9.96e-06	0.00317	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—ALB—Crohn's disease	9.62e-06	0.00306	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—FADS1—Crohn's disease	9.13e-06	0.00291	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—FADS1—Crohn's disease	8.99e-06	0.00286	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GPX4—Crohn's disease	8.55e-06	0.00272	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GPX4—Crohn's disease	8.42e-06	0.00268	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.37e-06	0.00267	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GCKR—Crohn's disease	8.25e-06	0.00263	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GCKR—Crohn's disease	8.13e-06	0.00259	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—ALB—Crohn's disease	7.48e-06	0.00238	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.4e-06	0.00236	CbGpPWpGaD
Zalcitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	7.3e-06	0.00233	CbGpPWpGaD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—ALB—Crohn's disease	6.67e-06	0.00212	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	6.57e-06	0.00209	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.25e-06	0.00199	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	5.47e-06	0.00174	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.32e-06	0.00169	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.24e-06	0.00167	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTMR3—Crohn's disease	4.65e-06	0.00148	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.14e-06	0.00132	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	3.95e-06	0.00126	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.88e-06	0.00124	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	3.8e-06	0.00121	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—FADS1—Crohn's disease	3.62e-06	0.00115	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GPX4—Crohn's disease	3.39e-06	0.00108	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTMR3—Crohn's disease	3.36e-06	0.00107	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GCKR—Crohn's disease	3.27e-06	0.00104	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	2.81e-06	0.000895	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	2.79e-06	0.000887	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	2.66e-06	0.000849	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ALB—Crohn's disease	2.63e-06	0.000837	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—FADS1—Crohn's disease	2.62e-06	0.000834	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ALB—Crohn's disease	2.59e-06	0.000824	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GPX4—Crohn's disease	2.45e-06	0.000781	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTMR3—Crohn's disease	2.39e-06	0.000761	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTMR3—Crohn's disease	2.37e-06	0.000755	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GCKR—Crohn's disease	2.37e-06	0.000754	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS2—Crohn's disease	2.3e-06	0.000732	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS2—Crohn's disease	2.26e-06	0.000721	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—FADS1—Crohn's disease	1.86e-06	0.000593	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—FADS1—Crohn's disease	1.85e-06	0.000588	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.84e-06	0.000585	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GPX4—Crohn's disease	1.74e-06	0.000555	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GPX4—Crohn's disease	1.73e-06	0.00055	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GCKR—Crohn's disease	1.68e-06	0.000536	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GCKR—Crohn's disease	1.67e-06	0.000532	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.56e-06	0.000498	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—FADS1—Crohn's disease	1.22e-06	0.000388	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.19e-06	0.00038	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GPX4—Crohn's disease	1.14e-06	0.000363	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GCKR—Crohn's disease	1.1e-06	0.000351	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.04e-06	0.000332	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALB—Crohn's disease	1.04e-06	0.000332	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—Crohn's disease	9.12e-07	0.00029	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALB—Crohn's disease	7.53e-07	0.00024	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—Crohn's disease	6.59e-07	0.00021	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALB—Crohn's disease	5.36e-07	0.000171	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALB—Crohn's disease	5.31e-07	0.000169	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—Crohn's disease	4.69e-07	0.000149	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—Crohn's disease	4.65e-07	0.000148	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALB—Crohn's disease	3.5e-07	0.000112	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.06e-07	9.76e-05	CbGpPWpGaD
